2019 Endowment Fund Grants: successful grant recipients
17 September 2019
Twenty-two new ground-breaking Peter Mac cancer research projects will be established thanks to the generosity of donors to the Foundation’s Perpetual Endowment Fund. In total, $1.1m in seed funding was awarded through the Foundation's 2019 Endowment Fund Grants program to help kick-start some of Peter Mac's most exciting new cancer research initiatives.
Our most grateful thanks go to the generous individuals who have enabled these annual Grants by donating to the Foundation's Endowment Fund.
Recipients of this year's Grants are:
Researcher |
Project Title |
Division |
---|---|---|
Alexander, Marliese |
Australian registry for ROS1 rearranged non-small cell lung cancer - a framework for prospective collection of clinical data and consent to access biospecimens. |
Cancer Medicine |
Atkin, Nicola |
An open-label, single-arm feasibility study of oral lorazepam for symptoms of anxiety in patients with advanced cancer. |
Chief Medical Officer |
Brennan, Amelia |
Overcoming tumour cell resistance to natural immunity and immunotherapy. |
Research |
Burdett, Nikki |
Emquest-Identifying factors which predict for health-related quality of life deficits and increased symptom burden in women who have been treated for endometrial cancer. |
Medical Oncology |
Christie, Liz |
Understanding spatial patterning of resistance in ovarian cancer. |
Cancer Research |
Clemons, Nicholas |
Multiplexed single-cell CRISPR activation and knockout tumourigenesis screen to establish functional genetic drivers of oesophageal adenocarcinoma. |
Cancer Research |
Haskali, Mohammad |
Development of Ga-68/Lu-177 labelled Carfilzomib for the diagnosis and therapy of Multiple Myeloma. |
Radiation Oncology |
Hoskins, Cass |
Young people's experiences of managing significantly increased risk of gastric cancer due to a CDH1 mutation. |
Parkville Familial Cancer Centre |
Joyce, Trish |
Precision preparation: Working with haematology patients and family carers to safely deliver outpatient complex cancer therapies. |
Nursing |
Lai, Junyun |
Using new generation CRISPR/Cas9-mediated genomic engineering to enhance CAR T-cell efficacy in solid cancers. |
Cancer Research |
Lewin, Jeremy |
RNAseq-based assay for diagnosis and clinical management of sarcoma. |
ONTrac at Peter Mac Victorian Adolescent & Young Adult Cancer Service |
Liddicoat, Brian |
Understanding the clonal evolution and maintenance of CAR T-cell persistence. |
Cancer Epigenetics |
Lonski, Peta |
3-dimensional modelling of radiation doses to the lungs of patients undergoing total body irradiation treatment for haematological malignancies. |
Radiation Oncology |
Lupat, Richard |
Powering Personalised Medicine through FPGA-based Ultra-Rapid Secondary Analysis of NGS Data. |
Cancer Research |
McDonald, Geraldine |
Supporting staff to deliver better EoL care. |
Chief Medical Officer |
Pereira, Lloyd |
A tumouroid based preclinical model for Adenoid Cystic Carcinoma of the Salivary Gland. |
Cancer Research |
Ryland, Georgina |
Identifying Ph-like B-acute lymphoblastic leukaemia - a poor risk subtype with the potential for targeted therapy. |
Centre for Clinical Cancer Genomics |
Smith, Cassandra |
Improving consumer engagement in cancer research: Identifying and minimising the barriers for consumers to partner with researchers. |
Medical |
Vassiliadis, Dane |
Single-cell analysis of non-genomic cancer cell adaptation to therapeutic intervention. |
Cancer Research |
Vervoort, Stephin |
Feature-seq: Simultaneous single cell RNA-sequencing and surface protein expression profiling on pooled mouse or patient tumour filtrating T-cell samples. |
Research (Translational Haematology) |
Voskoboinik, Ilia |
Understanding cancer cell resistance to cytotoxic lymphocytes and immunotherapy. |
Research |
Yong, Michelle |
Biomarker predictors for respiratory viral and fungal infections in malignant haematology and haematopoietic stem cell transplant recipients. |
Chief Medical Officer |